BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Early pregnancy factor
,
Phenobarbital
,
rs6983267
,
ERBB2
,
Leukemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
vasoactive intestinal peptide
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Expression of VIP and its receptors in the testis of the spotted ray Torpedo marmorata (Risso 1880).
Vasoactive intestinal peptide (VIP) inhibits human renal cell carcinoma proliferation.
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis.
Promotional effects of vasoactive intestinal peptide on the development of rodent Hertwig's epitheli…
Effects of VIP on corneal reconstitution and homeostasis following Pseudomonas aeruginosa induced ke…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Vasoactive Intestinal Peptide in COPD
Hemodynamic and Headache-Inducing Effect of Intravenous Vasoactive Intestinal Peptide in Migraineurs
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome …
The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) in Episodic Migraine P…
The Effects of a Long-lasting Infusion of Vasoactive Intestinal Peptide (VIP) on Headache, Cranial H…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ